Natural Compound-Driven Nano-Self-Assembly for Multimechanistic Transdermal Antiobesity Therapy.

Summary

A carrier-free nanodrug assembled from curcumin and glycyrrhetinic acid, delivered via dissolvable microneedles with black phosphorus and mild photothermal activation, remodeled subcutaneous fat in obese mice. The platform promoted browning, lipolysis, and favorable macrophage polarization, reducing body weight, increasing energy expenditure, and limiting weight regain after cessation.

Key Findings

• Carrier-free curcumin/glycyrrhetinic acid nanoparticles in dissolvable microneedles enabled efficient transdermal delivery with mild photothermal activation.
• In diet-induced obese mice, treatment reduced body weight, increased energy expenditure, and limited post-treatment weight regain.
• Mechanistically, therapy promoted white adipose browning, enhanced lipolysis, and modulated macrophage polarization toward anti-inflammatory states.

Clinical Implications

If safety and efficacy translate to humans, this could evolve into a minimally invasive adjunct for obesity and aesthetic body contouring, potentially reducing reliance on systemic drugs or surgical procedures.

Limitations

• Preclinical animal data only; human safety, dosing, and long-term durability remain untested.
• Potential photothermal and nanomaterial-related safety concerns require comprehensive toxicology.

Future Directions

Progress to GLP toxicology, pharmacokinetics, and first-in-human trials to assess safety, dose, and efficacy; evaluate usability and adherence for at-home aesthetic and metabolic applications.